CCND2 and atherosclerosis: Mechanistic studies revealed that RNCR3 binds to miR-185-5p, regulates cyclin D2 expression, and promotes cell growth and cytokine secretion, which suggests that RNCR3 may be a potential target for atherosclerosis treatment.